Error message

The MailChimp PHP library is missing the required GuzzleHttp library. Please check the installation notes in README.txt.

Warning message

The subscription service is currently unavailable. Please try again later.

About Bactiguard

Bactiguard is a Swedish medtech company offering an effective and patient friendly solution for infection prevention.
 

Our technology

Our patented technology has unlimited application potential.



 

Our products

We offer products preventing healthcare associated infections caused by medical devices for the urinary tract, respiratory tract and the bloodstream.

Healthcare associated infections

Everything you need to know about healthcare associated infections. 
 

BACTIGUARD'S INTERIM REPORT Q2

Bactiguard Holding AB (publ) published the interim report for the second quarter on Thursday August 13, 2020 at 07:30 CET. In connection with this, a webcast for investors, analysts and media was held at 10:00 CET on August 13 where CEO Cecilia Edström presented the interim report and answered questions. Bactiguard's new CFO Gabriella Björknert Caracciolo also participated.

Please find the webcast below:

Bactiguard prevents
healthcare associated infections

Every year millions of people are affected by healthcare associated infections, causing great patient suffering. Bactiguard´s antimicrobial and preventive solution reduces the number of healthcare associated infections related to the use of medical devices. By reducing healthcare associated infections we increase patient safety, reduce the use of antiobiotics ant thereby prevent the spread of multi-resistant bacteria, save significant costs for the healthcare system and most important of all, we save lives.

 

ACTUAL NEWS


September 12, 2020

Many patients affected by severe COVID-19 die from sepsis and its complications

While the number of global coronavirus infections has [...]
August 13, 2020

Interim report for Q2 2020

Strong growth and earnings development in quarter affected [...]
August 12, 2020

Health Canada provides COVID-19 Interim Order approval for Bactiguard’s endotracheal tubes

Health Canada has approved Bactiguard’s endotracheal [...]
August 13, 2020

Interim report for Q2 2020

Strong growth and earnings development in quarter affected [...]
August 12, 2020

Health Canada provides COVID-19 Interim Order approval for Bactiguard’s endotracheal tubes

Health Canada has approved Bactiguard’s endotracheal [...]
August 10, 2020

Invitation to the presentation of Bactiguard’s interim report on August 13, 2020

Bactiguard Holding AB (publ) publishes the interim report [...]
September 12, 2020

Many patients affected by severe COVID-19 die from sepsis and its complications

While the number of global coronavirus infections has [...]
November 18, 2019

The future of antibiotics depends on all of us

World Antibiotic Awareness Week (WAAW) is WHO initiative [...]
September 13, 2019

Bactiguard supports the World Sepsis Day

Sepsis is a global health crisis and every 3-4 seconds [...]

Calendar

November 05, 2020

Interim report for Q3

Interim report for Q3 

BACTIGUARD - SHARE

Subscribe to our news